Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis

• Principais autores: A. B. Prokofiev (Autor), S. A. Belkov (Autor), R. E. Kazakov (Autor), N. G. Berdnikova (Autor), T. A. Rodina (Autor), E. S. Melnikov (Autor), A. A. Danko (Autor), N. E. Voronova (Autor), R. Z. Vafina (Autor), A. V. Zavtoniev (Autor), D. V. Tsyganko (Autor), E. Yu. Demchenkova (Autor)
• Formato: Livro
• Publicado em: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Vancomycin is prescribed to patients in serious condition with infections caused by Gram-positive microorganisms; however, if the therapeutic plasma concentration of the medicinal product is exceeded, it can have a nephrotoxic effect.The aim of the study was to demonstrate the possibility of using t...